ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2183

Release of Enzymatically Active Peptidyl Arginine Deiminases (PADs) By Neutrophils Allows Generation of Citrullinated Extracellular Autoantigens in the Synovial Fluid of Patients with Rheumatoid Arthritis

Julia Spengler1, Bozo Lugonja2, Andrew Creese1, Jimmy Ytterberg3, Karin Lundberg4, Michael Milward1, Mark Pearson5, Christopher Buckley6, Andrew Filer1, Karim Raza7, Paul Cooper1, Iain Chapple8 and Dagmar Scheel-Toellner1, 1University of Birmingham, Birmingham, United Kingdom, 2Rheumatology Research Group, University of Birmingham Research Laboratories, University of Birmingham, Birmingham, United Kingdom, 3Medicine, Rheumatology Unit, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 4Rheumatology unit, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 5University of Birmihgham, Birmingham, United Kingdom, 6Rheumathology Research Group, University of Birmingham, Birmingham, United Kingdom, 7Rheumatology Research Group, University of Birmingham, Birmingham, United Kingdom, 8Periodontology Dept, School of Dentistry, University of Birmingham, Birmingham, United Kingdom

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Neutrophil Extracellular Traps, PAD and citrullination

  • Tweet
  • Email
  • Print
Session Information

Title: Innate Immunity and Rheumatic Disease: Mediators, Cells and Receptors

Session Type: Abstract Submissions (ACR)

Background/Purpose

Citrullinated proteins are important autoantigens in the inflamed joints of patients with rheumatoid arthritis (RA). Several of these proteins are derived from proteins generally found in the extracellular space, such as fibrinogen and type II collagen. It is therefore important to understand the source of extracellular peptidyl deiminases, (PAD) the enzymes responsible for citrullination. After entering the joints of RA patients, neutrophils are activated and release DNA in an active process termed NETosis. As this process involves histone citrullination by PAD4 we hypothesized that neutrophils undergoing NETosis in the rheumatoid joint release enzymatically active peptidyl arginine deiminases.

Methods

Extracellular DNA was quantified in the synovial fluid (SF) of patients with RA (n=27) and osteoarthritis (OA) (n=15). Presence of decondensed DNA in association with neutrophil elastase was studied on smear preparations of RA SF and synovial tissue. Release of PAD2 and PAD4 was examined during in vitro induced NETosis using Western Blotting and verified by mass spectrometry and immunofluorescence. NETS isolated from in vivo and in vitro activated neutrophils were isolated and probed on western blots. PAD activity in the supernatant of in vitro stimulated neutrophils and in the SF of patients with RA (n=7) and OA (n=9) was determined by a conversion assay involving citrullination of target peptides.

Results

Extracellular DNA was detected in the SF from RA patients at significantly higher levels than in OA SF (p<0.001) and correlated with SF neutrophil cell counts (n=15, R2=0.68, p=0.002) and with PAD activity (n=14, R2=0.32, p=0.03) in the SF. Immunofluorescence revealed the co-localization of neutrophil elastase with decondensed DNA in RA SF and within neutrophil precipitates on the surface of the synovial lining layer. Furthermore, PAD activity was detected at significantly higher levels in the SF of RA patients when compared to SF from OA patients (p<0.001) and the isoenzymes PAD2 and PAD4 were both found to be present in the SF of RA patients. Significantly higher PAD activity could also be detected in the supernatant of in vitro stimulated neutrophils when compared to unstimulated cells (p<0.05). Western blotting revealed the release of free PAD2 and PAD4 into the supernatant and also the association of both isoenzymes with isolated NETs. The loss of nuclear PAD4 signal during NETosis was confirmed by immunofluorescence staining.

Conclusion

These results demonstrate the enzymatic activity of PADs in the synovial fluid of RA patients. Combined with our findings from in vitro stimulated neutrophils the data suggest that neutrophils undergoing NETosis are a source of this extracellular activity. The correlation of the measured PAD activity with DNA levels and neutrophil cell counts in the synovial fluid of RA patients are in line with this hypothesis. This study highlights the possibility that activated neutrophils recruited into the joints could continuously release enzymatically active PADs which contribute to the continuous generation of citrullinated autoantigens and thus drive an inflammatory response in the joint.


Disclosure:

J. Spengler,
None;

B. Lugonja,
None;

A. Creese,
None;

J. Ytterberg,
None;

K. Lundberg,
None;

M. Milward,
None;

M. Pearson,
None;

C. Buckley,
None;

A. Filer,
None;

K. Raza,
None;

P. Cooper,
None;

I. Chapple,
None;

D. Scheel-Toellner,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/release-of-enzymatically-active-peptidyl-arginine-deiminases-pads-by-neutrophils-allows-generation-of-citrullinated-extracellular-autoantigens-in-the-synovial-fluid-of-patients-with-rheumatoid-arthr/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology